3 stories about NeuroDerm
ירון ויצנבליט PWC הייטק

After a Two-Years Slump, Israeli Tech M&A, IPOs, Up 110%

27.12.17|Amarelle Wenkert
U.S. buyers accounted for the majority of deals in 2017, with as many as 33 deals valued at $4.1 billion, according to a new report
מימין עודד ליברמן מנכל נוירודרם עם נציגי הרוכשת מיצובישי טנאבה

Mitsubishi Tanabe Pharma Finalizes $1.1 Billion Buy of Israel-Based NeuroDerm

19.10.17|Lilach Baumer
NeuroDerm is looking to bring major change to Parkinson patients with its drug reformulation
עובדי נוירודרם

Mitsubishi Tanabe Pharma to Buy Israel-Based NeuroDerm for $1.1 Billion

25.07.17|Gil Kalian
Osaka-based Mitsubishi Tanabe said it expects the deal would help it achieve sales of over $700 million in the U.S. by 2020